Abstract
ObjectivesWe examined patient-reported outcomes (PROs) in The Study of Etanercept And Methotrexate in Patients with Psoriatic Arthritis (PsA); a 48-week, phase 3, randomised controlled trial that compared outcomes with methotrexate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have